Pieris Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ADAR1 CAPITAL MANAGEMENT, LLC 10 percent owner
 Common Stock 2,243 $15.88 $35,623
Purchase
ADAR1 CAPITAL MANAGEMENT, LLC 10 percent owner
 Common Stock 757 $15.88 $12,023
Purchase
ADAR1 CAPITAL MANAGEMENT, LLC 10 percent owner
 Common Stock 3,000 $14.89 $44,679
Purchase
GERAGHTY JAMES A director
 Series F Preferred Stock, par value $0.001 per share 1 $1 $1
Purchase
KIRITSY CHRISTOPHER P director
 Common Stock 10,000 $0.85 $8,500
Purchase
DEMUTH TIM officer: Chief Medical Officer
 Common Stock 6,000 $1.71 $10,260
Option
OLWILL SHANE officer: Chief Development Offi..
 Stock Option (right to buy) 38,400 $1.52 $58,368
Sale
OLWILL SHANE officer: Chief Development Offi..
 Common Stock 9,200 $5 $46,000
Sale
OLWILL SHANE officer: Chief Development Offi..
 Common Stock 29,200 $5.15 $150,380
Option
OLWILL SHANE officer: Chief Development Offi..
 Common Stock 38,400 $1.52 $58,368
Sale
AQUILO CAPITAL MANAGEMENT, LLC 10 percent owner
 Common Stock, $0.001 par value 1,900,000 N/A N/A
Sale
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 50,000 N/A N/A
Purchase
KIRITSY CHRISTOPHER P director
 Common Stock 5,000 N/A N/A
Purchase
GERAGHTY JAMES A director
 Common Stock 10,000 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 1,000,000 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 1,000,000 $6.35 $6,350,000
Option
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Stock Option (right to buy) 6,057 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 7,897 N/A N/A
Option
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 7,897 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 7,897 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 1,709,620 N/A N/A
Option
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Stock Option (right to buy) 27,241 N/A N/A
Sale
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 147,635 N/A N/A
Option
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 147,635 N/A N/A
Option
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 147,635 $2.35 $346,942
Purchase
REINE ALLAN officer: Chief Financial Officer
 Common Stock 20,000 N/A N/A
Purchase
GERAGHTY JAMES A director
 Common Stock 10,000 N/A N/A
Purchase
REINE ALLAN officer: Chief Financial Officer
 Common Stock 45,000 N/A N/A
Option
KIRITSY CHRISTOPHER P director
 Stock Option (right to buy) 5,000 N/A N/A
Option
KIRITSY CHRISTOPHER P director
 Common Stock 5,000 N/A N/A
Purchase
MATIS LOUIS officer: Chief Development Offi..
 Common Stock 7,915 N/A N/A
Purchase
DEPTULA-HICKS DARLENE M officer: SVP, Chief Financial O..
 Common Stock 5,000 N/A N/A
Purchase
MATIS LOUIS officer: Chief Development Offi..
 Common Stock 2,085 N/A N/A
Purchase
YODER STEPHEN S. director, officer: Chief Execut..
 Common Stock 6,000 N/A N/A
Purchase
KHUONG CHAU QUANG director, 10 percent owner
 Common Stock 500,000 N/A N/A
Purchase
ORBIMED ADVISORS LLC 10 percent owner, other: See Re..
 Common Stock 500,000 N/A N/A

Showing 1 to 36 of 36 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: